(IHF) iShares U.S. Healthcare - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888287 • Health
IHF: Health, Providers, Services, Insurance, Hospitals, Pharmaceuticals
The iShares U.S. Healthcare Providers ETF (IHF) is designed to track the performance of companies within the healthcare providers sector in the U.S. equity market. This sector encompasses a range of businesses, including hospitals, health insurance providers, and medical services firms. The fund typically invests at least 80% of its assets in securities that are part of its underlying index or in investments that closely mirror these securities. This approach allows the fund to maintain a close alignment with the indexs performance. Additionally, up to 20% of its assets may be allocated to derivatives, such as futures and options, as well as cash and cash equivalents, providing flexibility in managing the portfolio. It is important to note that IHF is classified as a non-diversified fund, which means it may concentrate its holdings in a smaller number of securities, potentially leading to higher volatility compared to diversified funds. For more information, please visit the iShares website at http://www.ishares.com.
As of the latest available data, the iShares U.S. Healthcare Providers ETF (IHF) manages approximately $662.40 million in assets. This ETF is listed on the NYSE ARCA under the ticker symbol IHF and falls under the Health category. The funds focus on the healthcare providers sector makes it a targeted investment option for those looking to gain exposure to this specific area within the healthcare industry.
Looking ahead, the future outlook for the healthcare providers sector, as reflected by the iShares U.S. Healthcare Providers ETF (IHF), is influenced by several key factors. From a demographic perspective, the aging population in the U.S. is expected to drive increased demand for healthcare services, which could benefit companies in this sector. Additionally, ongoing developments in healthcare policy and regulation, such as potential reforms or changes in reimbursement models, could have significant implications for the sector. Technological advancements, particularly in areas like telemedicine and digital health platforms, may also play a role in shaping the future landscape of healthcare providers. Furthermore, the financial health of the sector will be closely tied to factors such as revenue growth, cost management, and valuations. As with any investment, it is important to consider these dynamics and how they may impact the performance of the ETF over time.Additional Sources for IHF ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IHF ETF Overview
Market Cap in USD | 693m |
Category | Health |
TER | 0.40% |
IPO / Inception | 2006-05-01 |
IHF ETF Ratings
Growth 5y | 40.6% |
Fundamental | - |
Dividend | 42.8% |
Rel. Strength Industry | -12.6 |
Analysts | - |
Fair Price Momentum | 48.80 USD |
Fair Price DCF | - |
IHF Dividends
Dividend Yield 12m | 0.80% |
Yield on Cost 5y | 1.43% |
Annual Growth 5y | 10.45% |
Payout Consistency | 60.9% |
IHF Growth Ratios
Growth Correlation 3m | 50.3% |
Growth Correlation 12m | -18.6% |
Growth Correlation 5y | 52.4% |
CAGR 5y | 11.87% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 0.03 |
Alpha | -11.17 |
Beta | 0.40 |
Volatility | 20.15% |
Current Volume | 98.3k |
Average Volume 20d | 87.1k |
What is the price of IHF stocks?
As of March 14, 2025, the stock is trading at USD 50.34 with a total of 98,277 shares traded.
Over the past week, the price has changed by -1.85%, over one month by -4.39%, over three months by +0.68% and over the past year by -5.34%.
As of March 14, 2025, the stock is trading at USD 50.34 with a total of 98,277 shares traded.
Over the past week, the price has changed by -1.85%, over one month by -4.39%, over three months by +0.68% and over the past year by -5.34%.
Is iShares U.S. Healthcare a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares U.S. Healthcare (NYSE ARCA:IHF) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.63 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHF as of March 2025 is 48.80. This means that IHF is currently overvalued and has a potential downside of -3.06%.
Partly, yes. Based on ValueRay Analyses, iShares U.S. Healthcare (NYSE ARCA:IHF) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.63 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHF as of March 2025 is 48.80. This means that IHF is currently overvalued and has a potential downside of -3.06%.
Is IHF a buy, sell or hold?
iShares U.S. Healthcare has no consensus analysts rating.
iShares U.S. Healthcare has no consensus analysts rating.
What are the forecast for IHF stock price target?
According to ValueRays Forecast Model, IHF iShares U.S. Healthcare will be worth about 53.2 in March 2026. The stock is currently trading at 50.34. This means that the stock has a potential upside of +5.68%.
According to ValueRays Forecast Model, IHF iShares U.S. Healthcare will be worth about 53.2 in March 2026. The stock is currently trading at 50.34. This means that the stock has a potential upside of +5.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 53.2 | 5.7% |